MedPath
TGA Approval

MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial (316240)

316240

MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial

Reach Pharmaceuticals Pty Ltd

August 26, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/40ae8a8d10e184e355fb41c8ead68a78.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/954829c494c6786b2b3c3dba60c902f5.pdf

Active Ingredients

cabazitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MSN CABAZITAXEL cabazitaxel 60 mg/1.5 mL concentrated injection vial and diluent vial (316240) - TGA 批准文号 | MedPath